文献速递垂体与肾上腺疾病

双侧肾上腺皮质结节性疾病与库欣综合征

Bilateral Adrenocortical Nodular Disease and Cushing's Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本文综述双侧肾上腺皮质结节性疾病两种主要形式:原发性色素性结节性肾上腺皮质病(PPNAD)和双侧大结节性肾上腺皮质病(BMAD),二者均可导致库欣综合征但特征迥异。PPNAD多见于年轻患者,常表现为严重的库欣综合征,以小于1厘米的色素性微结节为特征,影像学不一定可见;BMAD主要诊断于第五和第六个十年,皮质醇过量的程度高度可变,从轻度自主皮质醇分泌到明显的库欣综合征。两病常由遗传决定:PPNAD常与Carney复合征相关,约80%的索引病例可识别出种系遗传缺陷,主要影响cAMP/蛋白激酶A(PKA)通路的关键因子,最常见的是PRKAR1A;BMAD多表现为孤立性,目前已知两个易感基因:ARMC5约占索引病例的20%,以及最近发现的KDM1A,导致由肾上腺结节中葡萄糖依赖性促胰岛素多肽受体(GIPR)异位表达介导的食物依赖性库欣综合征的罕见表现。

要点

  • PPNAD多见于年轻患者,常表现为严重的库欣综合征,以小于1厘米的色素性微结节为特征,影像学不一定可见。
  • BMAD主要诊断于第五和第六个十年,皮质醇过量程度高度可变,从轻度自主皮质醇分泌到明显的库欣综合征。
  • PPNAD常与Carney复合征相关,约80%的索引病例可识别出种系遗传缺陷,主要影响cAMP/PKA通路的关键因子,最常见的是PRKAR1A。

核心结论

  • PPNAD和BMAD是两种截然不同的肾上腺皮质结节性疾病,均可导致库欣综合征,但临床、影像和遗传特征迥异。
  • 过去30年对双侧肾上腺皮质结节性疾病遗传学和病理生理学的理解取得了关键进展,促使对这些疾病采取个体化诊疗策略。

研究设计与样本

  • 综述性文章,总结双侧肾上腺皮质结节性疾病(PPNAD和BMAD)的临床、影像、遗传和病理生理学特征。

主要发现

  • PPNAD主要影响年轻患者,几乎总是表现为严重的库欣综合征,以小于1厘米的色素性微结节为特征,影像学不一定可见。
  • BMAD主要诊断于第五和第六个十年,皮质醇过量程度高度可变,从轻度自主皮质醇分泌到明显的库欣综合征,表现为双侧大肾上腺大结节,影像学容易观察到。
  • PPNAD常与Carney复合征相关,约80%的索引病例可识别出种系遗传缺陷,主要影响cAMP/PKA通路的关键因子,最常见的是PRKAR1A。
  • BMAD多表现为孤立性,目前已知两个易感基因:ARMC5约占索引病例的20%,以及最近发现的KDM1A,导致由肾上腺结节中GIPR异位表达介导的食物依赖性库欣综合征的罕见表现。
  • GIPR是第一个被证明在结节性肾上腺皮质疾病中非法调节皮质醇分泌的受体,此后发现了大量其他受体和旁分泌信号。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary pigmented nodular adrenocortical disease (PPNAD) and bilateral macronodular adrenocortical disease (BMAD) are 2 forms of adrenocortical nodular diseases causing Cushing's syndrome but are 2 very distinct conditions. PPNAD, affecting mostly young patients with an almost constant severe Cushing's syndrome, is characterized by pigmented micronodules, usually less than 1 cm, not always visible on imaging. On the contrary, BMAD is predominantly diagnosed in the fifth and sixth decades, with highly variable degrees of cortisol excess, from mild autonomous cortisol secretion to overt Cushing's syndrome. BMAD presents as large bilateral adrenal macronodules, easily observed on imaging. Both diseases are often genetically determined: frequently PPNAD is observed in a multiple neoplasia syndrome, Carney complex, and a germline genetic defect is identified in around 80% of index cases, always affecting key actors of the cAMP/protein kinase A (PKA) pathway: mostly PRKAR1A, encoding the PKA 1-alpha regulatory subunit. On the other hand, BMAD appears mostly isolated, and 2 predisposing genes are known at present: ARMC5, accounting for around 20% of index cases, and the recently identified KDM1A, causing the rare presentation with food-dependent Cushing's syndrome, mediated by the ectopic expression of the glucose-dependent insulinotropic polypeptide receptor (GIPR) in adrenal nodules. GIPR was the first demonstrated receptor to illegitimately regulate cortisol secretion in nodular adrenocortical diseases, and a myriad of other receptors and paracrine signals were discovered afterward. The last 30 years were pivotal in the understanding of the genetics and pathophysiology of bilateral adrenocortical nodular diseases, leading to a personalized approach of these fascinating conditions.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bouys L, Violon F, Louiset E, et al. Bilateral Adrenocortical Nodular Disease and Cushing's Syndrome. J Clin Endocrinol Metab. 2024. PMID: 38888184. doi:10.1210/clinem/dgae419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。